Medicine and Dentistry
Therapeutics
100%
Mortality
85%
Left Ventricular Systolic Dysfunction
85%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
85%
Endothelial Cell
85%
Congestive Heart Failure
85%
Therapeutic Procedure
42%
Sudden Death
42%
Patient
42%
Symptom
42%
Follow up
21%
New York Heart Association Class
21%
Prospective Cohort Study
21%
ACE Inhibitor
21%
Heart Ventricle Remodeling
21%
Outpatient
21%
Mortality Rate
21%
Beta Adrenergic Receptor Blocking Agent
21%
Chest
21%
Marker
21%
Oxidoreductase Inhibitor
14%
Human Insulin
14%
Small Interfering RNA
14%
Transgenic Mouse
14%
Vasodilatation
14%
Oxidative Stress
14%
Reactive Oxygen Species
14%
Biochemistry, Genetics and Molecular Biology
NAD(P)H Oxidase
85%
Cytotoxic Concentration
12%
Molecule
12%
Isoform
12%
Small Interfering RNA
12%